Literature DB >> 14961902

Circulating basement membrane zone antibodies are found in lichen sclerosus of the vulva.

Anne Howard1, Diane Dean, Susan Cooper, Gudula Kirtshig, Fenella Wojnarowska.   

Abstract

This study was undertaken to investigate the prevalence of basement membrane zone (BMZ) antibodies, their subtypes and clinical correlations in 96 patients attending the Oxford vulval clinic with lichen sclerosus (LS) of the vulva. Indirect immunofluorescence of serum (intact and split skin) to immunoglobulin (Ig)G was performed looking for the presence or absence of staining at the BMZ. Eighteen patients' sera (14 with positive indirect immunofluorescence to IgG) were examined for IgG antibodies of subclasses IgG1, 2 and 3, and 23 sera were examined for IgG4 subclass. Immunoblotting was performed in seven patients, and showed antibodies to BP180 in six patients and BP230 in one. One-third of patients with vulval LS had BMZ antibodies binding to the epidermal side of salt split skin. Immunoblotting showed antibodies to BP180 collagen XVII (six of seven patients) and BP230 in one. The subclasses were chiefly IgG1 and 2, different from those seen in bullous pemphigoid. No clinical correlation was found between the presence of antibodies and the presence of erosions, severity of scarring, age of onset of disease or response to treatment. These antibodies may be a reflection of a tendency to produce autoantibodies or be relevant to pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14961902     DOI: 10.1111/j.1440-0960.2004.00026.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  10 in total

Review 1.  Topical interventions for genital lichen sclerosus.

Authors:  Ching-Chi Chi; Gudula Kirtschig; Maha Baldo; Fabia Brackenbury; Fiona Lewis; Fenella Wojnarowska
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

Review 2.  Case Report: Bullous Pemphigoid Associated With Morphea and Lichen Sclerosus: Coincidental Diseases or Pathogenetic Association?

Authors:  Roberto Maglie; Maria Efenesia Baffa; Francesca Montefusco; Carlo Pipitò; Stefano Senatore; Marco Capassoni; Vincenza Maio; Marco Matucci Cerinic; Emiliano Antiga; Serena Guiducci
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

Review 3.  Vulvar lichen sclerosus in the elderly: pathophysiology and treatment update.

Authors:  Natalie A Saunders; Hope K Haefner
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 4.  Vulvar pruritus-Causes, Diagnosis and Therapeutic Approach.

Authors:  Linn Woelber; Katharina Prieske; Werner Mendling; Barbara Schmalfeldt; Hans-Jürgen Tietz; Anna Jaeger
Journal:  Dtsch Arztebl Int       Date:  2020-02-21       Impact factor: 5.594

5.  Lichen sclerosus in men is associated with elevated body mass index, diabetes mellitus, coronary artery disease and smoking.

Authors:  Matthias D Hofer; Joshua J Meeks; Nitin Mehdiratta; Michael A Granieri; John Cashy; Chris M Gonzalez
Journal:  World J Urol       Date:  2013-04-30       Impact factor: 4.226

Review 6.  Lichenoid vulvar disease: A review.

Authors:  R Fruchter; L Melnick; M K Pomeranz
Journal:  Int J Womens Dermatol       Date:  2017-03-27

Review 7.  Genital lichen planus: An underrecognized entity.

Authors:  Ananta Khurana; Sidharth Tandon; Yogesh S Marfatia; Nina Madnani
Journal:  Indian J Sex Transm Dis AIDS       Date:  2019 Jul-Dec

Review 8.  Penile Lichen Sclerosis: A Surgical Perspective of its Aetiology and Treatment.

Authors:  Dhiraj Bhambhani; Suresh Bhambhani; Nitin Kumar Pandya
Journal:  Cureus       Date:  2022-08-26

9.  Granuloma annulare, autoimmune thyroiditis, and lichen sclerosus in a woman: randomness or significant association?

Authors:  Mariele De Paola; Anastasia Batsikosta; Luca Feci; Mattia Benedetti; Roberta Bilenchi
Journal:  Case Rep Dermatol Med       Date:  2013-05-07

Review 10.  Diagnosis and treatment of lichen sclerosus: an update.

Authors:  Susanna K Fistarol; Peter H Itin
Journal:  Am J Clin Dermatol       Date:  2013-02       Impact factor: 7.403

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.